Triamcinolone diacetate

双醋酸曲安西龙

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameTriamcinolone diacetate
Drug Alias NameTriamcinolone, Diacetate de曲安西龙双醋酸酯Triamcinoloni DiacetasDiacetato de triamcinolonaAristocort
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucocorticoid receptor agonists
TargetsGlucocorticoid receptor
Therapy Area/IndicationsPlaque psoriasisDrug HypersensitivityThyroiditis, Subacute +[59] 
Global Approved IndicationsDrug HypersensitivityDermatitis, ContactLupus Erythematosus, Discoid +[10] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1959/03/12
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShanghai Fosun Pharmaceutical (Group) Co Ltd
Active IndicationsN/A
Inactive IndicationsPlaque psoriasisDrug HypersensitivityThyroiditis, Subacute +[59] 

Other Information

ATC CodeA01AC01C05AA12D07AB09 +[8] 
Related LinksWikipediaDrugBankKEGG